Human beta defensin levels and vaginal microbiome composition in post-menopausal women diagnosed with lichen sclerosus

Abstract Human beta defensins (hBDs) may play an important role in the progression of lichen sclerosus (LS), due to their ability to induce excessive stimulation of extracellular matrix synthesis and fibroblast activation. The genetic ability of the individual to produce defensins, the presence of m...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Alexandra Brunner, Márta Medvecz, Nóra Makra, Miklós Sárdy, Kinga Komka, Máté Gugolya, Dóra Szabó, Márió Gajdács, Eszter Ostorházi
Formato: article
Lenguaje:EN
Publicado: Nature Portfolio 2021
Materias:
R
Q
Acceso en línea:https://doaj.org/article/66e68bd00524467aaa5c69062564601e
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:66e68bd00524467aaa5c69062564601e
record_format dspace
spelling oai:doaj.org-article:66e68bd00524467aaa5c69062564601e2021-12-02T18:49:30ZHuman beta defensin levels and vaginal microbiome composition in post-menopausal women diagnosed with lichen sclerosus10.1038/s41598-021-94880-42045-2322https://doaj.org/article/66e68bd00524467aaa5c69062564601e2021-08-01T00:00:00Zhttps://doi.org/10.1038/s41598-021-94880-4https://doaj.org/toc/2045-2322Abstract Human beta defensins (hBDs) may play an important role in the progression of lichen sclerosus (LS), due to their ability to induce excessive stimulation of extracellular matrix synthesis and fibroblast activation. The genetic ability of the individual to produce defensins, the presence of microbes influencing defensin production, and the sensitivity of microbes to defensins together regulate the formation of an ever-changing balance between defensin levels and microbiome composition. We investigated the potential differences in postmenopausal vaginal microbiome composition and vaginal hBD levels in LS patients compared to non-LS controls. LS patients exhibited significantly lower levels of hBD1 (p = 0.0003), and significantly higher levels of hBD2 (p = 0.0359) and hBD3 (p = 0.0002), compared to the control group. The microbiome of the LS patients was dominated by possibly harmful bacteria including Lactobacillus iners, Streptococcus anginosus or Gardnerella vaginalis known to initiate direct or indirect damage by increasing defensin level production. Our observations highlight that correcting the composition of the microbiome may be applicable in supplementary LS therapy by targeting the restoration of the beneficial flora that does not increase hBD2-3 production.Alexandra BrunnerMárta MedveczNóra MakraMiklós SárdyKinga KomkaMáté GugolyaDóra SzabóMárió GajdácsEszter OstorháziNature PortfolioarticleMedicineRScienceQENScientific Reports, Vol 11, Iss 1, Pp 1-11 (2021)
institution DOAJ
collection DOAJ
language EN
topic Medicine
R
Science
Q
spellingShingle Medicine
R
Science
Q
Alexandra Brunner
Márta Medvecz
Nóra Makra
Miklós Sárdy
Kinga Komka
Máté Gugolya
Dóra Szabó
Márió Gajdács
Eszter Ostorházi
Human beta defensin levels and vaginal microbiome composition in post-menopausal women diagnosed with lichen sclerosus
description Abstract Human beta defensins (hBDs) may play an important role in the progression of lichen sclerosus (LS), due to their ability to induce excessive stimulation of extracellular matrix synthesis and fibroblast activation. The genetic ability of the individual to produce defensins, the presence of microbes influencing defensin production, and the sensitivity of microbes to defensins together regulate the formation of an ever-changing balance between defensin levels and microbiome composition. We investigated the potential differences in postmenopausal vaginal microbiome composition and vaginal hBD levels in LS patients compared to non-LS controls. LS patients exhibited significantly lower levels of hBD1 (p = 0.0003), and significantly higher levels of hBD2 (p = 0.0359) and hBD3 (p = 0.0002), compared to the control group. The microbiome of the LS patients was dominated by possibly harmful bacteria including Lactobacillus iners, Streptococcus anginosus or Gardnerella vaginalis known to initiate direct or indirect damage by increasing defensin level production. Our observations highlight that correcting the composition of the microbiome may be applicable in supplementary LS therapy by targeting the restoration of the beneficial flora that does not increase hBD2-3 production.
format article
author Alexandra Brunner
Márta Medvecz
Nóra Makra
Miklós Sárdy
Kinga Komka
Máté Gugolya
Dóra Szabó
Márió Gajdács
Eszter Ostorházi
author_facet Alexandra Brunner
Márta Medvecz
Nóra Makra
Miklós Sárdy
Kinga Komka
Máté Gugolya
Dóra Szabó
Márió Gajdács
Eszter Ostorházi
author_sort Alexandra Brunner
title Human beta defensin levels and vaginal microbiome composition in post-menopausal women diagnosed with lichen sclerosus
title_short Human beta defensin levels and vaginal microbiome composition in post-menopausal women diagnosed with lichen sclerosus
title_full Human beta defensin levels and vaginal microbiome composition in post-menopausal women diagnosed with lichen sclerosus
title_fullStr Human beta defensin levels and vaginal microbiome composition in post-menopausal women diagnosed with lichen sclerosus
title_full_unstemmed Human beta defensin levels and vaginal microbiome composition in post-menopausal women diagnosed with lichen sclerosus
title_sort human beta defensin levels and vaginal microbiome composition in post-menopausal women diagnosed with lichen sclerosus
publisher Nature Portfolio
publishDate 2021
url https://doaj.org/article/66e68bd00524467aaa5c69062564601e
work_keys_str_mv AT alexandrabrunner humanbetadefensinlevelsandvaginalmicrobiomecompositioninpostmenopausalwomendiagnosedwithlichensclerosus
AT martamedvecz humanbetadefensinlevelsandvaginalmicrobiomecompositioninpostmenopausalwomendiagnosedwithlichensclerosus
AT noramakra humanbetadefensinlevelsandvaginalmicrobiomecompositioninpostmenopausalwomendiagnosedwithlichensclerosus
AT miklossardy humanbetadefensinlevelsandvaginalmicrobiomecompositioninpostmenopausalwomendiagnosedwithlichensclerosus
AT kingakomka humanbetadefensinlevelsandvaginalmicrobiomecompositioninpostmenopausalwomendiagnosedwithlichensclerosus
AT mategugolya humanbetadefensinlevelsandvaginalmicrobiomecompositioninpostmenopausalwomendiagnosedwithlichensclerosus
AT doraszabo humanbetadefensinlevelsandvaginalmicrobiomecompositioninpostmenopausalwomendiagnosedwithlichensclerosus
AT mariogajdacs humanbetadefensinlevelsandvaginalmicrobiomecompositioninpostmenopausalwomendiagnosedwithlichensclerosus
AT eszterostorhazi humanbetadefensinlevelsandvaginalmicrobiomecompositioninpostmenopausalwomendiagnosedwithlichensclerosus
_version_ 1718377564602368000